Solasto Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Solasto şirketinin toplam hissedar öz sermayesi ¥21.5B ve toplam borcu ¥22.3B olup, bu da borç-öz sermaye oranını 103.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥70.5B ve ¥49.0B dir. Solasto 'in FAVÖK'ü ¥6.7B faiz karşılama oranı 22.6 dur. Şirketin ¥12.3B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

103.7%

Borç/özkaynak oranı

JP¥22.33b

Borç

Faiz karşılama oranı	22.6x
Nakit	JP¥12.31b
Eşitlik	JP¥21.53b
Toplam yükümlülükler	JP¥48.97b
Toplam varlıklar	JP¥70.50b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality

Nov 19

Here's What Analysts Are Forecasting For Solasto Corporation (TSE:6197) After Its Interim Results

Nov 14

Why Investors Shouldn't Be Surprised By Solasto Corporation's (TSE:6197) 29% Share Price Surge

Sep 04

Solasto (TSE:6197) Will Pay A Dividend Of ¥10.00

Aug 13

There May Be Reason For Hope In Solasto's (TSE:6197) Disappointing Earnings

May 21

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 6197 'nin kısa vadeli varlıkları ( ¥30.2B ) kısa vadeli yükümlülüklerini ( ¥21.7B ) aşıyor.

Uzun Vadeli Yükümlülükler: 6197 şirketinin kısa vadeli varlıkları ( ¥30.2B ) uzun vadeli yükümlülüklerini ( ¥27.3B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 6197 'nin net borç/öz sermaye oranı ( 46.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 6197 şirketinin borç/öz sermaye oranı son 5 yılda 90.6% seviyesinden 103.7% seviyesine yükseldi.

Borç Kapsamı: 6197 'nin borcu işletme nakit akışı ( 18.4% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 6197 'in borcuna ilişkin faiz ödemeleri EBIT ( 22.6 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Solasto Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality

Here's What Analysts Are Forecasting For Solasto Corporation (TSE:6197) After Its Interim Results

Second quarter 2025 earnings released: EPS: JP¥11.73 (vs JP¥5.29 in 2Q 2024)

Solasto Corporation to Report Q2, 2025 Results on Nov 11, 2024

Upcoming dividend of JP¥10.00 per share

Price target increased by 11% to JP¥693

Why Investors Shouldn't Be Surprised By Solasto Corporation's (TSE:6197) 29% Share Price Surge

Solasto (TSE:6197) Will Pay A Dividend Of ¥10.00

Dividend of JP¥10.00 announced

First quarter 2025 earnings released: EPS: JP¥9.25 (vs JP¥35.82 in 1Q 2024)

High number of new directors

Solasto Corporation to Report Q1, 2025 Results on Aug 08, 2024

Price target decreased by 17% to JP¥643

Consensus EPS estimates fall by 37%

There May Be Reason For Hope In Solasto's (TSE:6197) Disappointing Earnings

Full year 2024 earnings: EPS misses analyst expectations

Solasto Corporation to Report Fiscal Year 2024 Results on May 13, 2024

Upcoming dividend of JP¥10.00 per share

Price target decreased by 10% to JP¥770

Third quarter 2024 earnings released: EPS: JP¥5.54 (vs JP¥8.70 in 3Q 2023)

Solasto Corporation to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings released: EPS: JP¥5.29 (vs JP¥9.98 in 2Q 2023)

Solasto Corporation Announces Executive Changes

Solasto Corporation to Report Q2, 2024 Results on Nov 08, 2023

Upcoming dividend of JP¥10.00 per share at 3.3% yield

Price target decreased by 11% to JP¥1,000

New major risk - Revenue and earnings growth

New minor risk - Earnings quality

First quarter 2024 earnings released: EPS: JP¥35.82 (vs JP¥9.60 in 1Q 2023)

Solasto Corporation (TSE:6197) announces an Equity Buyback for 3,000,000 shares, representing 3.17% for ¥1,500 million.

Solasto Corporation to Report Q1, 2024 Results on Aug 10, 2023

Solasto Corporation (TSE:6197) sign a contract to acquire 96.63% stake in POSSIBLE Medical Science, Ltd. from West Japan Railway Company (TSE:9021) for ¥1.3 billion.

Price target decreased by 8.5% to JP¥1,142

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Solasto Corporation, Annual General Meeting, Jun 27, 2023

Third quarter 2023 earnings released: EPS: JP¥8.70 (vs JP¥11.39 in 3Q 2022)

Solasto Corporation (TSE:6197) acquired Kabushikigaisha Morishin.

Solasto Corporation to Report Q3, 2023 Results on Feb 08, 2023

Price target decreased to JP¥1,356

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥9.98 (vs JP¥11.26 in 2Q 2022)

Solasto Corporation to Report Q2, 2023 Results on Oct 17, 2022

Upcoming dividend of JP¥10.00 per share

Solasto Corporation to Report Q2, 2023 Results on Nov 09, 2022

First quarter 2023 earnings released: EPS: JP¥9.60 (vs JP¥11.33 in 1Q 2022)

Solasto Corporation to Report Q1, 2023 Results on Jul 21, 2022

Solasto Corporation to Report Q1, 2023 Results on Aug 10, 2022

Price target decreased to JP¥1,430

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Solasto Corporation, Annual General Meeting, Jun 27, 2022

Consensus forecasts updated

Price target decreased to JP¥1,650

Less than half of directors are independent

Solasto Corporation to Report Fiscal Year 2022 Results on May 11, 2022

Solasto Corporation (TSE:6197) agreed to acquire Nanairo Co., Ltd.

Solasto Corporation (TSE:6197) acquired Hug Hug Kids Co., Ltd.

Price target decreased to JP¥1,650

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Solasto Corporation (TSE:6197) sign a contract to acquire Cocoro Care Plan Corporation from Kiyoshi Yoshioka for ¥3.3 billion.

Second quarter 2022 earnings released: EPS JP¥11.26 (vs JP¥12.30 in 2Q 2021)

Upcoming dividend of JP¥10.00 per share

Full year 2021 earnings released: EPS JP¥37.50 (vs JP¥50.32 in FY 2020)

Upcoming dividend of JP¥10.00 per share

New 90-day low: JP¥1,438

Solasto Corporation Revises Earnings Forecast for the Fiscal Year 2021

Third quarter 2021 earnings released: EPS JP¥10.88 (vs JP¥9.83 in 3Q 2020)

Revenue beats expectations, earnings disappoint

New 90-day high: JP¥1,640

Solasto Corporation to Report Q3, 2021 Results on Feb 09, 2021

Price target raised to JP¥1,814

Solasto Corporation to Report Q2, 2021 Results on Nov 10, 2020

Solasto Corporation (TSE:6197) sign a contract to acquire 5c's Healthcare Co.,Ltd

Solasto Corporation (TSE:6197) agreed to acquire part of nursing care business of Lifesupport co.,Ltd.

Solasto Corporation (TSE:6197) entered into a contract to acquire Japan Elderly Care Service Inc. from ACA healthcare saihen 2 gou investment limited and ACA Inc. for ¥2.3 billion.

Solasto Corporation to Report Q1, 2021 Results on Aug 12, 2020